Exec Chat: Focus On Protecting Cybersecurity Vulnerabilities That Are Exploitable, Sternum CEO Says
Sternum recently announced a partnership with Medtronic to protect its legacy devices from cybersecurity threats. Medtech Insight chatted with its CEO Natali Tshuva about how her product works.
You may also be interested in...
US regulators say Verily’s Study Watch – meant to be used in Parkinson’s trials – doesn’t collect data needed to assess whether a patient is truly benefitting from a drug.
The US regulator’s report is meant to help develop new federal cybersecurity purchasing guidelines that could eventually be used to implement a cybersecurity consumer labeling program.
This week’s podcast highlights Medtech Insight’s coverage of Medtronic's decision to pull its HeartWare Ventricular Assist Device from the market and the implications of the move, as well as Biden's proposed budget that would increase funding for the US FDA.